Assessment of New Radiation Oncology Technologies and Treatments

NCT01379872 · clinicaltrials.gov ↗

COMPLETED

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Post Prostatectomy)
Anal Cancer
Nasopharyngeal Cancer
Intermediate Risk Prostate Cancer

Interventions

OTHER: Non-Interventional Study

Sponsor

Trans Tasman Radiation Oncology Group